Wednesday opened with an engaging Keynote Presentation by Dr. Christine Mummery from Leiden University on Cardiomyocytes from Human Pluripotent Stem Cells: The New Patient in Safety Pharmacology, Drug Discovery and Disease.
Dr. Mummery discussed and presented data on derivation of heart cells from
Over 400 attendees from across the globe are participating in the SPS Annual meeting this week.
Tuesday opened with an ECG historical talk by Dr. Marc Vos, and the Introduction to Tracks talks by Dr. Jack Reynolds and Dr. Jean-Pierre Valentin (via WebEx!) Their talks covered both the Challenges for
Today, 200 registrants participated in our CE Courses, Mini Course and Author Workshop. What a great way to start the Meeting!
The SPS CE Lunchtime Mini Course, chaired by Mark Deurinck, Novartis, is one of the highlights of the SPS Annual Meeting. In this course, three case studies will be presented by renowned safety pharmacology experts. Each case study will consist of a 15-minute presentation followed by a 5-min Q&A.
The Continuing Education (CE) courses provide excellent lectures to participants at Annual Meetings. The SPS PM 3 Continuing Education Course, chaired by Scott Mittelstadt, PhD, Abbott Laboratories and Mark A. Osinski, PhD, Covance Laboratories Inc. is a featured course for 2012.